FDA NDC Directory · JSON-LD · Markdown

levothyroxine sodium

NDC 47781-665 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAlvogen, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA021116
Dosage form / routeTABLET · ORAL
Active ingredientsLEVOTHYROXINE SODIUM (175 ug/1)
Marketing started20190507
Package count2

External sources

Source: openFDA. Public-domain (CC0).